Very rapid effect of pitavastatin on microvascular function in comparison to rosuvastatin: reactive hyperemia peripheral arterial tonometric study

References

• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 1994 344 8934 1383 1389 7968073
   PubMed Web of Science ®Google Scholar
• Shepherd J Cobbe SM Ford I Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group N Engl J Med 1995 333 20 1301 1307 7566020
   PubMed Web of Science ®Google Scholar
• Kirmizis D Papagianni A Dogrammatzi F Effects of simvastatin on markers of inflammation, oxidative stress and endothelial cell apoptosis in patients on chronic hemodialysis J Atheroscler Thromb 2010 17 12 1256 1265 20885069
   PubMed Web of Science ®Google Scholar
• Takemoto M Liao JK Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors Arterioscler Thromb Vasc Biol 2001 21 11 1712 1719 11701455
   PubMed Web of Science ®Google Scholar
• O’Driscoll G Green D Taylor RR Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month Circulation 1997 95 5 1126 1131 9054840
   PubMed Web of Science ®Google Scholar
• Nonogaki K Suzuki M Kanai N Sumii M Kaji T Short-term effect of pitavastatin on the reactive hyperemic index in post-menopausal women with high levels in serum LDL-cholesterol Int J Cardiol 2011 150 2 227 228 21636141
   PubMed Web of Science ®Google Scholar
• Tsunekawa T Hayashi T Kano H Cerivastatin, a hydroxy-methylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days Circulation 2001 104 4 376 379 11468195
   PubMed Web of Science ®Google Scholar
• Wassmann S Faul A Hennen B Scheller B Bohm M Nickenig G Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function Circ Res 2003 93 9 e98 e103 14551237
   PubMed Web of Science ®Google Scholar
• Sakabe K Fukuda N Fukuda Y Comparisons of short- and intermediate-term effects of pitavastatin versus atorvastatin on lipid profiles, fibrinolytic parameter, and endothelial function Int J Cardiol 2008 125 1 136 138 17400311
   PubMed Web of Science ®Google Scholar
• Toi T Taguchi I Yoneda S Early effect of lipid-lowering therapy with pitavastatin on regression of coronary atherosclerotic plaque. Comparison with atorvastatin Circ J 2009 73 8 1466 1472 19531899
   PubMed Web of Science ®Google Scholar
• Bonetti PO Barsness GW Keelan PC Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease J Am Coll Cardiol 2003 41 10 1761 1768 12767662
   PubMed Web of Science ®Google Scholar
• Hamburg NM Keyes MJ Larson MG Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study Circulation 2008 117 19 2467 2474 18458169
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y Sugiyama S Sugamura K Digital assessment of endothelial function and ischemic heart disease in women J Am Coll Cardiol 2010 55 16 1688 1696 20394872
   PubMed Web of Science ®Google Scholar
• Rubinshtein R Kuvin JT Soffler M Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events Eur Heart J 2010 31 9 1142 1148 20181680
   PubMed Web of Science ®Google Scholar
• Corretti MC Anderson TJ Benjamin EJ Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 2002 39 2 257 265 11788217
   PubMed Web of Science ®Google Scholar
• Gokce N Keaney JFJr Hunter LM Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease J Am Coll Cardiol 2003 41 10 1769 1775 12767663
   PubMed Web of Science ®Google Scholar
• Shimada K Fukuda S Maeda K Aromatherapy alleviates endothelial dysfunction of medical staff after night-shift work: preliminary observations Hypertens Res 2011 34 2 264 267 21107332
   PubMed Web of Science ®Google Scholar
• Hijmering ML Stroes ES Pasterkamp G Sierevogel M Banga JD Rabelink TJ Variability of flow mediated dilation: consequences for clinical application Atherosclerosis 2001 157 2 369 373 11472736
   PubMed Web of Science ®Google Scholar
• Hamburg NM Palmisano J Larson MG Relation of brachial and digital measures of vascular function in the community: the Framingham heart study Hypertension 2011 57 3 390 396 21263120
   PubMed Web of Science ®Google Scholar
• Schnabel RB Schulz A Wild PS Noninvasive vascular function measurement in the community: cross-sectional relations and comparison of methods Circ Cardiovasc Imaging 2011 4 4 371 380 21551420
   PubMed Web of Science ®Google Scholar
• Nohria A Gerhard-Herman M Creager MA Hurley S Mitra D Ganz P Role of nitric oxide in the regulation of digital pulse volume amplitude in humans J Appl Physiol 2006 101 2 545 548 16614356
   PubMed Web of Science ®Google Scholar
• Livalo®(pitavastatin) [prescribing information] Tokyo, Japan Kowa Company, Ltd 2010
   Google Scholar
• Crestor®(rosuvastatin) [prescribing information] Osaka, Japan AstraZeneca 2011
   Google Scholar
• Wolfrum S Dendorfer A Rikitake Y Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection Arterioscler Thromb Vasc Biol 2004 24 10 1842 1847 15319269
   PubMed Web of Science ®Google Scholar
• Jantzen F Konemann S Wolff B Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells J Physiol Pharmacol 2007 58 3 503 514 17928646
   PubMed Web of Science ®Google Scholar
• Kim MC Ahn Y Jang SY Comparison of clinical outcomes of hydrophilic and lipophilic statins in patients with acute myocardial infarction Korean J Intern Med 2011 26 3 294 303 22016590
   PubMedGoogle Scholar
• Davignon J Pleiotropic effects of pitavastatin Br J Clin Pharmacol 2012 73 4 518 535 22053916
   PubMed Web of Science ®Google Scholar
• Catapano AL Statin-induced myotoxicity: pharmacokinetic differences among statins and the risk of rhabdomyolysis, with particular reference to pitavastatin Curr Vasc Pharmacol 2012 10 2 257 267 22022768
   PubMed Web of Science ®Google Scholar
• Kitta Y Obata JE Nakamura T Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease J Am Coll Cardiol 2009 53 4 323 330 19161880
   PubMed Web of Science ®Google Scholar
• Yoshino S Hamasaki S Ishida S Relationship between bilirubin concentration, coronary endothelial function, and inflammatory stress in overweight patients J Atheroscler Thromb 2011 18 5 403 412 21350306
   PubMed Web of Science ®Google Scholar
• Corsini A Ceska R Drug-drug interactions with statins: will pitavastatin overcome the statins’ Achilles’ heel? Curr Med Res Opin 2011 27 8 1551 1562 21682551
   PubMed Web of Science ®Google Scholar
• Ghiadoni L Magagna A Versari D Kardasz I Huang Y Taddei S Salvetti A Different effect of antihypertensive drugs on conduit artery endothelial function Hypertension 2003 41 6 1281 1286 12719441
   PubMed Web of Science ®Google Scholar
• Wassmann S Hilgers S Laufs U Bohm M Nickenig G Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction Arterioscler Thromb Vasc Biol 2002 22 7 1208 1212 12117739
   PubMed Web of Science ®Google Scholar
• Fukuda S Shimada K Maeda K Circadian variation in coronary flow velocity reserve and its relation to alpha1-sympathetic activity in humans Int J Cardiol 2012 157 2 216 220 21194761
   PubMed Web of Science ®Google Scholar